Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

PICC management led by technicians: Establishment of a cooperation program with radiologists and evaluation of complications.

Chasseigne V, Larbi A, Goupil J, Bouassida I, Buisson M, Beregi JP, Frandon J.

Diagn Interv Imaging. 2019 Jul 16. pii: S2211-5684(19)30163-9. doi: 10.1016/j.diii.2019.06.010. [Epub ahead of print]

PMID:
31324590
2.

Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort study.

Murall CL, Rahmoun M, Selinger C, Baldellou M, Bernat C, Bonneau M, Boué V, Buisson M, Christophe G, D'Auria G, Taroni F, Foulongne V, Froissart R, Graf C, Grasset S, Groc S, Hirtz C, Jaussent A, Lajoie J, Lorcy F, Picot E, Picot MC, Ravel J, Reynes J, Rousset T, Seddiki A, Teirlinck M, Tribout V, Tuaillon É, Waterboer T, Jacobs N, Bravo IG, Segondy M, Boulle N, Alizon S.

BMJ Open. 2019 Jun 11;9(6):e025129. doi: 10.1136/bmjopen-2018-025129.

3.

Sex-Related Differences in Management and Outcome of Acute Ischemic Stroke in Eligible Patients to Thrombolysis.

Fraticelli L, Freyssenge J, Claustre C, Buisson M, Bischoff M, Nighoghossian N, Derex L, El Khoury C; on behalf of the RESUVal Group.

Cerebrovasc Dis. 2019;47(3-4):196-204. doi: 10.1159/000500901. Epub 2019 May 23.

PMID:
31121582
4.

Remote ischemic conditioning in septic shock (RECO-Sepsis): study protocol for a randomized controlled trial.

Cour M, Buisson M, Klouche K, Bouzgarrou R, Schwebel C, Quenot JP, Zeni F, Beuret P, Ovize M, Argaud L.

Trials. 2019 May 22;20(1):281. doi: 10.1186/s13063-019-3406-4.

5.

MRI Profile and Collateral Status in Patients with a Transient Ischemic Attack and an Intracranial Artery Occlusion.

Ong E, Eker O, Chamard L, Cho TH, Derex L, Buisson M, Mechtouff L, Berthezene Y, Nighoghossian N.

J Neuroimaging. 2019 Mar;29(2):187-189. doi: 10.1111/jon.12560. Epub 2018 Sep 12.

PMID:
30209849
6.

Unexplained bone pain and sexual addiction.

Crépin JC, Blot M, Buisson M, Piroth L.

BMJ Case Rep. 2018 Jun 4;2018. pii: bcr-2018-225380. doi: 10.1136/bcr-2018-225380. No abstract available.

PMID:
29866696
7.

Impact of Brain Atrophy on Early Neurological Deterioration and Outcome in Severe Ischemic Stroke Treated by Intravenous Thrombolysis.

Tschirret O, Moreno Legast G, Mansuy A, Mewton N, Buisson M, Hannoun S, Chamard L, Sappey-Marinier D, El Khoury C, Bischoff M, de Parisot A, Derex L, Nighoghossian N, Berthezène Y, Mechtouff L.

Eur Neurol. 2018;79(5-6):240-246. doi: 10.1159/000487668. Epub 2018 Apr 19.

PMID:
29672312
8.

Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD.

Habib M, Buisson M, Lupo J, Agbalika F, Socié G, Germi R, Baccard M, Imbert-Marcille BM, Dantal J, Morand P, Drouet E.

Sci Rep. 2017 Sep 5;7(1):10479. doi: 10.1038/s41598-017-09798-7.

9.

Effect of Cyclosporine on Lesion Growth and Infarct Size within the White and Gray Matter.

Ong E, Mewton N, Bouvier J, Chauveau F, Ritzenthaler T, Mechtouff L, Derex L, Buisson M, Berthezène Y, Ovize M, Nighoghossian N, Cho TH.

Front Neurol. 2017 Apr 27;8:151. doi: 10.3389/fneur.2017.00151. eCollection 2017.

10.

Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.

Prendki V, Ferry T, Sergent P, Oziol E, Forestier E, Fraisse T, Tounes S, Ansart S, Gaillat J, Bayle S, Ruyer O, Borlot F, Le Falher G, Simorre B, Dauchy FA, Greffe S, Bauer T, Bell EN, Martha B, Martinot M, Froidure M, Buisson M, Waldner A, Lemaire X, Bosseray A, Maillet M, Charvet V, Barrelet A, Wyplosz B, Noaillon M, Denes E, Beretti E, Berlioz-Thibal M, Meyssonnier V, Fourniols E, Tliba L, Eden A, Jean M, Arvieux C, Guignery-Kadri K, Ronde-Oustau C, Hansmann Y, Belkacem A, Bouchand F, Gavazzi G, Herrmann F, Stirnemann J, Dinh A.

Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1577-1585. doi: 10.1007/s10096-017-2971-2. Epub 2017 Apr 4.

PMID:
28378243
11.

COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.

Akodad M, Lattuca B, Nagot N, Georgescu V, Buisson M, Cristol JP, Leclercq F, Macia JC, Gervasoni R, Cung TT, Cade S, Cransac F, Labour J, Dupuy AM, Roubille F.

Arch Cardiovasc Dis. 2017 Jun - Jul;110(6-7):395-402. doi: 10.1016/j.acvd.2016.10.004. Epub 2017 Jan 3.

12.

Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials.

Rehman MB, Tudrej BV, Soustre J, Buisson M, Archambault P, Pouchain D, Vaillant-Roussel H, Gueyffier F, Faillie JL, Perault-Pochat MC, Cornu C, Boussageon R.

Diabetes Metab. 2017 Feb;43(1):48-58. doi: 10.1016/j.diabet.2016.09.005. Epub 2016 Oct 10.

PMID:
27745828
13.

Duration of first-line antiretroviral therapy in HIV-infected treatment-naive patients in routine practice.

Tesson T, Blot M, Fillion A, Djerad H, Cagnon-Chapalain J, Creuwels A, Waldner A, Duong M, Buisson M, Mahy S, Chavanet P, Piroth L.

Antivir Ther. 2016;21(8):715-724. doi: 10.3851/IMP3084. Epub 2016 Sep 7.

PMID:
27599563
14.

Ensemble Structure of the Highly Flexible Complex Formed between Vesicular Stomatitis Virus Unassembled Nucleoprotein and its Phosphoprotein Chaperone.

Yabukarski F, Leyrat C, Martinez N, Communie G, Ivanov I, Ribeiro EA Jr, Buisson M, Gerard FC, Bourhis JM, Jensen MR, Bernadó P, Blackledge M, Jamin M.

J Mol Biol. 2016 Jul 3;428(13):2671-94. doi: 10.1016/j.jmb.2016.04.010. Epub 2016 Apr 21.

PMID:
27107640
15.

Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.

Garcia AI, Buisson M, Damiola F, Tessereau C, Barjhoux L, Verny-Pierre C, Sornin V, Dondon MG, Eon-Marchais S; GENESIS investigators, Caron O, Gautier-Villars M, Coupier I, Buecher B, Vennin P, Belotti M, Lortholary A, Gesta P, Dugast C, Noguès C, Fricker JP, Faivre L, Stoppa-Lyonnet D, Andrieu N, Sinilnikova OM, Mazoyer S.

Eur J Hum Genet. 2016 Aug;24(9):1324-9. doi: 10.1038/ejhg.2015.284. Epub 2016 Jan 20.

16.

Production and characterisation of Epstein-Barr virus helicase-primase complex and its accessory protein BBLF2/3.

Thierry E, Brennich M, Round A, Buisson M, Burmeister WP, Hutin S.

Virus Genes. 2015 Oct;51(2):171-81. doi: 10.1007/s11262-015-1233-6. Epub 2015 Aug 21.

PMID:
26292944
17.

Occurrence of a non deleterious gene conversion event in the BRCA1 gene.

Tessereau C, Léoné M, Buisson M, Duret L, Sinilnikova OM, Mazoyer S.

Genes Chromosomes Cancer. 2015 Oct;54(10):646-52. doi: 10.1002/gcc.22278. Epub 2015 Jul 14.

PMID:
26171949
18.

On the collapse pressure of armored bubbles and drops.

Pitois O, Buisson M, Chateau X.

Eur Phys J E Soft Matter. 2015 May;38(5):132. doi: 10.1140/epje/i2015-15048-9. Epub 2015 May 26.

PMID:
26002529
19.

Structure determination of feline calicivirus virus-like particles in the context of a pseudo-octahedral arrangement.

Burmeister WP, Buisson M, Estrozi LF, Schoehn G, Billet O, Hannas Z, Sigoillot C, Poulet H.

PLoS One. 2015 Mar 20;10(3):e0119289. doi: 10.1371/journal.pone.0119289. eCollection 2015.

20.

Erroneous event count in a meta-analysis (dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus).

Buisson M, Cornu C, Nony P.

Am J Cardiol. 2015 Mar 15;115(6):852. doi: 10.1016/j.amjcard.2014.11.016. Epub 2014 Nov 26. No abstract available.

PMID:
25554535
21.

Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing.

Tessereau C, Lesecque Y, Monnet N, Buisson M, Barjhoux L, Léoné M, Feng B, Goldgar DE, Sinilnikova OM, Mousset S, Duret L, Mazoyer S.

Nucleic Acids Res. 2014 Aug;42(14):9121-30. doi: 10.1093/nar/gku639. Epub 2014 Jul 17.

22.

Informal consultation at a teaching hospital infectious diseases department.

Rameau C, Mahy S, Simonet Lamm AL, Fillion A, Buisson M, Waldner A, Duong M, Piroth L, Chavanet P.

Med Mal Infect. 2014 Mar;44(3):107-11. doi: 10.1016/j.medmal.2014.01.009. Epub 2014 Mar 4.

PMID:
24612506
23.

Direct visualization of the highly polymorphic RNU2 locus in proximity to the BRCA1 gene.

Tessereau C, Buisson M, Monnet N, Imbert M, Barjhoux L, Schluth-Bolard C, Sanlaville D, Conseiller E, Ceppi M, Sinilnikova OM, Mazoyer S.

PLoS One. 2013 Oct 11;8(10):e76054. doi: 10.1371/journal.pone.0076054. eCollection 2013.

24.

BRCA2 deep intronic mutation causing activation of a cryptic exon: opening toward a new preventive therapeutic strategy.

Anczuków O, Buisson M, Léoné M, Coutanson C, Lasset C, Calender A, Sinilnikova OM, Mazoyer S.

Clin Cancer Res. 2012 Sep 15;18(18):4903-9. doi: 10.1158/1078-0432.CCR-12-1100. Epub 2012 Jul 2.

25.

The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection.

Horst D, Burmeister WP, Boer IG, van Leeuwen D, Buisson M, Gorbalenya AE, Wiertz EJ, Ressing ME.

J Virol. 2012 Sep;86(17):9175-87. doi: 10.1128/JVI.00309-12. Epub 2012 Jun 13.

26.

Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.

Lupo J, Germi R, Semenova T, Buisson M, Seigneurin JM, Morand P.

Clin Vaccine Immunol. 2012 Jun;19(6):929-34. doi: 10.1128/CVI.00100-12. Epub 2012 Apr 25.

27.

Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.

Houdayer C, Caux-Moncoutier V, Krieger S, Barrois M, Bonnet F, Bourdon V, Bronner M, Buisson M, Coulet F, Gaildrat P, Lefol C, Léone M, Mazoyer S, Muller D, Remenieras A, Révillion F, Rouleau E, Sokolowska J, Vert JP, Lidereau R, Soubrier F, Sobol H, Sevenet N, Bressac-de Paillerets B, Hardouin A, Tosi M, Sinilnikova OM, Stoppa-Lyonnet D.

Hum Mutat. 2012 Aug;33(8):1228-38. doi: 10.1002/humu.22101. Epub 2012 May 11.

PMID:
22505045
28.

[Recurrent atypical mycobacterial infections in the adult: think of autoantibodies against interferon-gamma !].

Picque JB, Blot M, Binois R, Jeudy G, Simonet AL, Cagnon J, Mahy S, Duong M, Buisson M, Chavanet P, Piroth L.

Rev Med Interne. 2012 Feb;33(2):103-6. doi: 10.1016/j.revmed.2011.11.012. Epub 2012 Jan 10. French.

PMID:
22236500
29.

Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.

Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS, Lidereau R, Mikaélian I, Mazoyer S.

EMBO Mol Med. 2011 May;3(5):279-90. doi: 10.1002/emmm.201100136. Epub 2011 Apr 5.

30.

[Vaccination coverage of healthcare professionals in an infectious diseases department].

Duong M, Mahy S, Binois R, Buisson M, Piroth L, Chavanet P.

Med Mal Infect. 2011 Mar;41(3):135-9. doi: 10.1016/j.medmal.2010.11.018. Epub 2010 Dec 30. French.

PMID:
21195571
31.

EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.

van Gent M, Griffin BD, Berkhoff EG, van Leeuwen D, Boer IG, Buisson M, Hartgers FC, Burmeister WP, Wiertz EJ, Ressing ME.

J Immunol. 2011 Feb 1;186(3):1694-702. doi: 10.4049/jimmunol.0903120. Epub 2010 Dec 29.

32.

A missense variant within BRCA1 exon 23 causing exon skipping.

Rouleau E, Lefol C, Moncoutier V, Castera L, Houdayer C, Caputo S, Bièche I, Buisson M, Mazoyer S, Stoppa-Lyonnet D, Noguès C, Lidereau R.

Cancer Genet Cytogenet. 2010 Oct 15;202(2):144-6. doi: 10.1016/j.cancergencyto.2010.07.122. No abstract available.

PMID:
20875879
33.

[Various aspects of intestinal tuberculosis].

Lhoumeau A, Al Samman S, Mahy S, Charon-Barra C, Buisson M, Duong M, Chavanet P, Ortega-Deballon P, Piroth L.

Med Mal Infect. 2010 Nov;40(11):654-6. doi: 10.1016/j.medmal.2010.03.012. Epub 2010 Apr 18. French. No abstract available.

PMID:
20400253
34.

Ocular syphilis and HIV infection.

Biotti D, Bidot S, Mahy S, Buisson M, Duong M, Grappin M, Creuzot-Garcher C, Chavanet P, Piroth L.

Sex Transm Dis. 2010 Jan;37(1):41-3. doi: 10.1097/OLQ.0b013e3181b3e4d8.

PMID:
20118676
35.

Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.

Larrat S, Morand P, Bas A, Vigne S, Crance JM, Boyer V, Nicod S, Grossi L, Buisson M, Burmeister WP, Seigneurin JM, Germi R.

Antivir Ther. 2009;14(5):655-62.

PMID:
19704168
36.

The flexible motif V of Epstein-Barr virus deoxyuridine 5'-triphosphate pyrophosphatase is essential for catalysis.

Freeman L, Buisson M, Tarbouriech N, Van der Heyden A, Labbé P, Burmeister WP.

J Biol Chem. 2009 Sep 11;284(37):25280-9. doi: 10.1074/jbc.M109.019315. Epub 2009 Jul 7.

37.

A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities.

Buisson M, Géoui T, Flot D, Tarbouriech N, Ressing ME, Wiertz EJ, Burmeister WP.

J Mol Biol. 2009 Aug 28;391(4):717-28. doi: 10.1016/j.jmb.2009.06.034. Epub 2009 Jun 16.

PMID:
19538972
38.

[Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port].

Crisinel M, Mahy S, Ortega-Debalon P, Buisson M, Favre JP, Chavanet P, Piroth L.

Med Mal Infect. 2009 Apr;39(4):252-8. doi: 10.1016/j.medmal.2008.11.004. Epub 2008 Dec 23. French.

PMID:
19108966
39.

Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues.

Zetoune AB, Fontanière S, Magnin D, Anczuków O, Buisson M, Zhang CX, Mazoyer S.

BMC Genet. 2008 Dec 5;9:83. doi: 10.1186/1471-2156-9-83.

40.

Unclassified variants identified in BRCA1 exon 11: Consequences on splicing.

Anczuków O, Buisson M, Salles MJ, Triboulet S, Longy M, Lidereau R, Sinilnikova OM, Mazoyer S.

Genes Chromosomes Cancer. 2008 May;47(5):418-26. doi: 10.1002/gcc.20546.

PMID:
18273839
41.

Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?

Anczuków O, Ware MD, Buisson M, Zetoune AB, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S.

Hum Mutat. 2008 Jan;29(1):65-73.

PMID:
17694537
42.

Limitation of exercise capacity in nucleoside-treated HIV-infected patients with hyperlactataemia.

Duong M, Dumas JP, Buisson M, Martha B, Piroth L, Grappin M, Waldner A, Chavanet P, Portier H.

HIV Med. 2007 Mar;8(2):105-11.

43.
44.

Kinetics, inhibition and oligomerization of Epstein-Barr virus protease.

Buisson M, Rivail L, Hernandez JF, Jamin M, Martinez J, Ruigrok RW, Burmeister WP.

FEBS Lett. 2006 Dec 11;580(28-29):6570-8. Epub 2006 Nov 14.

45.

Structural genomics of the Epstein-Barr virus.

Tarbouriech N, Buisson M, Géoui T, Daenke S, Cusack S, Burmeister WP.

Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1276-85. Epub 2006 Sep 19.

PMID:
17001105
46.

[Pyogenic psoas abscess: six cases and review of the literature].

Audia S, Martha B, Grappin M, Duong M, Buisson M, Couaillier JF, Lorcerie B, Chavanet P, Portier H, Piroth L.

Rev Med Interne. 2006 Nov;27(11):828-35. Epub 2006 Aug 15. Review. French.

PMID:
16959381
47.

The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon.

Buisson M, Anczuków O, Zetoune AB, Ware MD, Mazoyer S.

Hum Mutat. 2006 Oct;27(10):1024-9.

PMID:
16941470
48.

Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy.

Duong M, Petit JM, Martha B, Galland F, Piroth L, Walldner A, Grappin M, Buisson M, Duvillard L, Chavanet P, Portier H.

HIV Clin Trials. 2006 Mar-Apr;7(2):41-7.

PMID:
16798618
49.

The monomeric dUTPase from Epstein-Barr virus mimics trimeric dUTPases.

Tarbouriech N, Buisson M, Seigneurin JM, Cusack S, Burmeister WP.

Structure. 2005 Sep;13(9):1299-310. Erratum in: Structure. 2006 Mar;14(3):623.

50.

Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export.

Hiriart E, Gruffat H, Buisson M, Mikaelian I, Keppler S, Meresse P, Mercher T, Bernard OA, Sergeant A, Manet E.

J Biol Chem. 2005 Nov 4;280(44):36935-45. Epub 2005 Aug 29.

Supplemental Content

Loading ...
Support Center